|
ONCOLOGY: Practical, Peer-Reviewed Perspectives |
Volume 33, Number 8
|
Click here for the Digital Edition |
|
|
Atezolizumab and Its Many Uses |
Naveed Saleh, MD, MS
Atezolizumab is an immune checkpoint inhibitor that has been approved by the US Food and Drug Administration in various combinations for a number of cancer types in recent years. Here is a closer look at this important drug and its expanding uses.
|
Read more
|
|
|
Current Clinical Trials in Prostate Cancer
|
Naveed Saleh, MD, MS Prostate cancer is the most frequent cancer found in American men, and the second leading cause of cancer death in this population. Currently, scores of reputable clinical trials are underway and recruiting patients.
|
Read more
|
|
|
|
|